147 related articles for article (PubMed ID: 9336173)
1. Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils.
Kindzelskii AL; Eszes MM; Todd RF; Petty HR
Biophys J; 1997 Oct; 73(4):1777-84. PubMed ID: 9336173
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
Kindzelskii AL; Laska ZO; Todd RF; Petty HR
J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477
[TBL] [Abstract][Full Text] [Related]
3. Modeling the influence of ectodomain affinities on the spatial distribution of membrane receptors.
Weinand RG; Rosenspire AJ; Petty HR
J Theor Biol; 1999 Mar; 197(2):217-25. PubMed ID: 10074395
[TBL] [Abstract][Full Text] [Related]
4. Aberrant integrin (CR4; alpha(x)beta2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum.
Shaya S; Kindzelskii AL; Minor J; Moore EC; Todd RF; Petty HR
J Invest Dermatol; 1998 Jul; 111(1):154-8. PubMed ID: 9665403
[TBL] [Abstract][Full Text] [Related]
5. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.
Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR
J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767
[TBL] [Abstract][Full Text] [Related]
6. Urokinase receptor (uPAR) regulates complement receptor 3 (CR3)-mediated neutrophil phagocytosis.
Pliyev BK; Arefieva TI; Menshikov MY
Biochem Biophys Res Commun; 2010 Jun; 397(2):277-82. PubMed ID: 20580686
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils.
Sitrin RG; Pan PM; Blackwood RA; Huang J; Petty HR
J Immunol; 2001 Apr; 166(8):4822-5. PubMed ID: 11290756
[TBL] [Abstract][Full Text] [Related]
8. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.
Xue W; Kindzelskii AL; Todd RF; Petty HR
J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of integrin alpha M beta 2 ligand-binding function by the urokinase-type plasminogen activator receptor.
Tang ML; Kong LS; Law SK; Tan SM
Biochem Biophys Res Commun; 2006 Sep; 348(3):1184-93. PubMed ID: 16905120
[TBL] [Abstract][Full Text] [Related]
11. Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils.
Sitrin RG; Johnson DR; Pan PM; Harsh DM; Huang J; Petty HR; Blackwood RA
Am J Respir Cell Mol Biol; 2004 Feb; 30(2):233-41. PubMed ID: 12933356
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
Yebra M; Goretzki L; Pfeifer M; Mueller BM
Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
14. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.
Sitrin RG; Todd RF; Albrecht E; Gyetko MR
J Clin Invest; 1996 Apr; 97(8):1942-51. PubMed ID: 8621779
[TBL] [Abstract][Full Text] [Related]
15. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
Pliyev BK; Antonova OA; Menshikov M
Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
[TBL] [Abstract][Full Text] [Related]
16. Nonproteolytic role for the urokinase receptor in cellular migration in vivo.
Waltz DA; Fujita RM; Yang X; Natkin L; Zhuo S; Gerard CJ; Rosenberg S; Chapman HA
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):316-22. PubMed ID: 10696068
[TBL] [Abstract][Full Text] [Related]
17. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
18. Urokinase anchors uPAR to the actin cytoskeleton.
Bernstein AM; Greenberg RS; Taliana L; Masur SK
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2967-77. PubMed ID: 15326109
[TBL] [Abstract][Full Text] [Related]
19. Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes.
Sitrin RG; Pan PM; Harper HA; Blackwood RA; Todd RF
J Immunol; 1999 Dec; 163(11):6193-200. PubMed ID: 10570311
[TBL] [Abstract][Full Text] [Related]
20. Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations of migrating neutrophils.
Amit A; Kindzelskii AL; Zanoni J; Jarvis JN; Petty HR
Cell Immunol; 1999 May; 194(1):47-53. PubMed ID: 10357880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
